If the 3 announcements we’re expecting this quarter as listed in the last Quarterly are in the order they’re going to be released then the FTO pre clinical activity announcement should drop during the next 2 weeks as my calculations have the George Clinical breast cancer trial review due around 26th of February if the 13 week timetable is on time. Leaving the AML programmes sometime in March. Maybe Dr T could advise if the expected announcements were listed in the order they’re expected.
RAC Price at posting:
$2.79 Sentiment: Buy Disclosure: Held
